Revised. Amendments from Version 1
==================================

We thank the reviewers for the insightful comments. Based on the comments, we have made changes to and updated our article. In the abstract, the conclusion has been refined to make it more specific. To explain the difference in fasting glucose between the urban and rural settings, we have included pancreatic beta cell function as an outcome and reported the results. Occupation, as a possible proxy for activity levels, was added to the adjusted models and the new results from the analyses are presented in Tables 2 and 3. To further explore the role helminths in any observed differences in metabolic outcomes, the impact of  *S. mansoni *infection intensity was analysed and the results are shown in Table 5. In the discussion, we made changes to highlight the relatively young study population and incorporated our previous trial findings. Furthermore, we included the possibility of non-compliance to overnight fasting and emphasised the role of diet and socioeconomic status in partially explaining the differences observed in the two settings.

Introduction
============

Globally, non-communicable diseases (NCDs) are the leading cause of mortality and disability. In 2016, they contributed to 72.3% of deaths ^[@ref-1]^, and cardiometabolic disorders were the top contributors to disability adjusted life years ^[@ref-2]^. The World Health Organisation (WHO) estimates that 78% of NCD related deaths occur in low and middle income countries and that the NCD burden is rapidly increasing in these countries ^[@ref-3]^. Sub-Saharan Africa, a region undergoing rapid economic growth, is experiencing this epidemiological transition, with the double burden of NCDs and communicable diseases.

The increased NCD burden has been linked to urbanisation and, currently, more than half of the world's population lives in urban areas ^[@ref-4]^. Urban living is associated with traditional risk factors for cardiometabolic disease such as diets rich in energy-dense foods and reduced physical activity. This may suggest that the rural environment is protective against cardiometabolic diseases and various data sources confirm this ^[@ref-5]--\ [@ref-7]^. However, there are reports of an increasing or already high burden of NCDs such as hypertension and diabetes in rural areas ^[@ref-8]--\ [@ref-10]^ and no difference in burden between urban and rural settings ^[@ref-11]^. An increase in body mass index in rural areas has been identified as the main driver of the global epidemic of obesity ^[@ref-12]^.

The hygiene hypothesis proposes that the increase in chronic inflammatory disorders in high-income countries is linked to cleaner environments and less exposure to infectious agents ^[@ref-13]^. Exposure to infectious agents such as helminths modulates the immune system and may provide protection against these disorders. The urban environment is associated with less exposure to helminths compared to the rural environment. Recently, chronic inflammation has been linked to the aetiology of cardiometabolic disorders such as type 2 diabetes ^[@ref-14]^ and atherosclerosis ^[@ref-15]^, and has been proposed to have a role in essential hypertension ^[@ref-16]^. It remains unclear whether reduced exposure to helminth infections has contributed to the increase, and rural-urban differences, in cardiometabolic disease. There is evidence from animal studies, and the few published human studies, that through their effects on inflammation and metabolism, helminth infections are associated with favourable metabolic outcomes ^[@ref-17]--\ [@ref-19]^.

We therefore tested the hypothesis that the rural environment is protective against metabolic risk factors and diseases and that helminths play a role in this. We investigated differences in metabolic parameters between a rural, high helminth transmission setting and an urban, lower helminth transmission setting in Uganda. We also investigated whether helminths might explain any differences observed between the two settings.

Methods
=======

Study design and setting
------------------------

We conducted parallel cross-sectional surveys, one in a rural and one in an urban setting ( [Figure 1](#f1){ref-type="fig"}). The rural survey was the metabolic outcomes survey of the *Lake Victoria Island Intervention Study on Worms and Allergy-related diseases* (LaVIISWA). LaVIISWA was a cluster-randomised trial investigating the effects of intensive versus standard anthelminthic intervention on health outcomes in 26 rural Lake Victoria island communities of Koome sub-county, Mukono district, Uganda (population, 18,778) ^[@ref-20],\ [@ref-21]^. The metabolic outcomes survey was conducted between April and November 2017 after four years of the anthelminthic intervention ^[@ref-22]^. The survey in the urban setting was deliberately formulated to collect data in parallel with the LaVIISWA outcome surveys to enable rural-urban comparison of allergy-related ^[@ref-23],\ [@ref-24]^ and metabolic outcomes. It was conducted in Entebbe municipality, Wakiso district, Uganda from September 2016 to September 2017. Entebbe municipality is classified by the Uganda Bureau of Statistics as an urban area ^[@ref-25]^, and is located on the northern shores of Lake Victoria, with a population of 69,958 residing in 24 sub-wards (the smallest administrative units) ^[@ref-25]^.

![Location of the study areas.](wellcomeopenres-5-17864-g0000){#f1}

Participants
------------

Household surveys were conducted in both settings. Households with members available at the time of conducting the surveys were eligible for inclusion. In the rural setting, the study team, in collaboration with the local leaders, maintained an updated register of all the households in the 26 study villages. This was used as a sampling frame to randomly select 70 households in each of the 26 study villages using Stata software (College Station, Texas, USA). In the urban setting, a different sampling technique was used because resources and time could not permit a complete household listing before starting the survey. With the help of locally available maps, we mapped each sub-ward onto satellite imagery of the area excluding areas that were uninhabited. The mapped sub-wards were then divided into segments of equal geographical size based on lines of latitude and longitude (degrees, minutes, seconds position format) and each segment was numbered. Using random number generation, segments were randomly selected from each sub-ward. The number of segments selected was proportional to the population size of the sub-ward. The midpoint of each selected segment was identified by its coordinates using a using a geographic information system (GIS) device (eTrex ^®^, Garmin™ Ltd, Kansas, United States). This was used as the starting point for sampling households and the nearest house was selected for inclusion. Houses were then sequentially selected, the next house to be sampled being the nearest to the previous house. In total, 120 geographical segments were targeted in the 24 sub-wards and in each segment, four households were targeted. If a household was empty or refused, the next one was approached until the number per segment was completed.

In both surveys, a household was defined as a habitable roofed structure whose primary function was residence or, if used for dual purposes, had at least one active resident using the structure as their primary residence. In selected and participating households, permission was sought from the household head or another adult in the household if the household head was absent. Households where all members refused to participate, or where all members were absent during the survey period, were excluded. All survey questions are described in the Codebook of the *Underlying data* ^[@ref-26]^.

Variables
---------

The exposure variables were the rural/urban setting and helminth infection status. The outcomes were insulin resistance (measured using the homeostatic model assessment of insulin resistance (HOMA-IR; HOMA-IR = fasting serum insulin x fasting glucose / 22.5), fasting blood glucose, total cholesterol, triglyceride levels, High Density Lipoprotein (HDL) - cholesterol and low density lipoprotein (LDL) -- cholesterol, blood pressure, body mass index (BMI), waist and hip circumference. Following a reviewer's suggestion, we also included mean pancreatic beta cell function (HOMA-B) as an outcome. HOMA-B was calculated using the formula, HOMA-B=(20 × fasting insulin (μIU/ml)/fasting glucose (mmol/ml) − 3.5)\].

Data sources/ study procedures
------------------------------

The tools and procedures of both surveys were aligned to allow comparison of the metabolic outcomes data between urban and rural settings. A questionnaire was administered to consenting household members. With this questionnaire, data were collected on household and individual sociodemographic characteristics as well as information on lifestyle, exercise or vigorous physical activity, diet, history of diabetes and hypertension.

A physical examination was performed and information obtained on blood pressure, weight, height, waist and hip circumference. With the participant seated, rested and comfortable, blood pressure was measured using a digital sphygmomanometer (OMRON Model M2\[hem-7121-E\], Omron Health Care, Kyoto, Japan). Three blood pressure measurements were taken five minutes apart, with the average of the last two measurements used for the analysis. A portable, flat digital weighing scale (SECA model 875 7021094, Hamburg, Germany) was used to take two measurements of body weight for each participant and the average of the two readings computed and used in the analysis. Height was measured using a stadiometer (SECA model 213 1721009, Hamburg, Germany) and recorded to the nearest millimetre. Two readings were obtained and the mean was used in the analysis. Quality control checks, using standard calibration rods for the stadiometers and standard weights for the weighing scales, were performed at the beginning of each working day. The sphygmomanometers were calibrated by the Uganda Bureau of Standards.

After an overnight fast, participants provided venous blood samples. The tests carried out on these samples included fasting blood glucose, insulin, fasting lipid profile and haemoparasitology. Fasting blood glucose, insulin and fasting lipid profile were tested using the COBAS *cobas* 6000 analyser ( *cobas* c 501 module, Roche Diagnostics, Rotkreuz, Switzerland). *Mansonella perstans* was tested using the modified Knott's method ^[@ref-27]^.

Each participant was requested to provide one stool sample. Duplicate slides were made from each sample and the slides independently examined using the Kato Katz technique ^[@ref-28]^ by experienced technicians. Additionally, real-time stool polymerase chain reaction (PCR) was used to detect *Schistosoma mansoni*, *Necator americanus* and *Strongyloides stercoralis* ^[@ref-29],\ [@ref-30]^.

Diabetes and impaired fasting glucose were defined, according to the WHO classification, as fasting plasma glucose of ≥7.0 mmol/L and 6.1--6.9 mmol/L, respectively ^[@ref-31],\ [@ref-32]^. Hypertension was defined as diastolic blood pressure of ≥90 mmHg or systolic blood pressure of ≥140 mmHg in participants ≥18 years of age ^[@ref-33]^. Participants \<18 years old were categorised to be hypertensive if their systolic or diastolic blood pressures were above the 95 ^th^ percentile using the Centers for Disease Control blood pressure charts for children and adolescents ^[@ref-34]^.

Sample size
-----------

In the rural setting, we aimed to recruit 1950 participants (sampling 70 households without replacement was expected to yield 75 participants aged ≥10 years from each of the 26 villages). This number was primarily calculated for the LaVIISWA trial analysis and was estimated to give 80% power to detect a difference in mean HOMA-IR of 0.05 between the trial arms assuming an intra-cluster correlation coefficient of 0.03 and a standard deviation on the log scale of 0.2. In the urban survey, we targeted a sample size of 960 individuals aged ten and over, and estimated that this would allow us to detect an absolute difference of 0.03 in mean HOMA-IR between urban and rural settings, assuming a standard deviation on the log scale of 0.2, and a design effect of 1.5. Assuming a 13% failure rate in household response and an average of around 2.3 individuals aged ≥10 years per household 480 households were targeted.

Statistical methods
-------------------

The statistical analyses were performed using Stata version 13.0 (College Station, Texas, USA). We tabulated the characteristics of households and individuals in the urban setting alongside those of the rural setting in order to see how these differed between the two settings. We compared the outcomes between the rural setting and the urban setting. We summarised the mean for each outcome in the two settings and then assessed for differences by fitting regression models for each outcome that included a random effect to allow for the clustering (by village for the rural setting, by sub-ward for the urban setting) and a binary covariate that denoted whether the individual is in the urban or rural setting. Crude and adjusted mean differences and 95% confidence intervals are presented. All the outcomes were initially adjusted for age and sex and further adjusted for occupation, exercise, alcohol intake and smoking. HOMA-IR, fasting glucose, triglycerides, LDL-cholesterol, HDL-cholesterol, systolic and diastolic blood pressure were additionally adjusted for BMI. We did not perform any adjustments for multiple testing. In all analyses, data from the rural setting comprised all participants regardless of whether they had received intensive or standard anthelminthic treatment, i.e. both arms of the LaVIISWA trial were included. This was done because there were no strong differences in the outcomes between the trial arms ^[@ref-22]^.

To investigate whether helminths influence the differences observed in the metabolic outcomes, each helminth variable was added separately to the model and any change in the mean difference, confidence interval and p-values were assessed. Helminths were considered to have an influence on the urban-rural differences if addition of the variable resulted in a substantial change in the mean difference.

Ethical approval and consent
----------------------------

Ethical approval was granted by the Uganda Virus Research Institute Research Ethics committee (reference number GC/127/17/01/573), the Uganda National Council for Science and Technology (reference number HS 2185) and the London School of Hygiene and Tropical Medicine (reference number 9917). Permission to conduct the surveys was granted by the local leadership of Mukono district (for the rural survey) and Entebbe municipality (for the urban survey). All participating adults and emancipated minors provided written informed consent. Participants aged 10 to 17 years provided assent and their parents/guardians provided written informed consent.

Results
=======

Participants
------------

The survey flow is shown in [Figure 2](#f2){ref-type="fig"}. In the rural setting, 2167 individuals aged 10 years and above from 1271 households were eligible for participation. Of these, 1898/2167 (87.6%) consented and provided data. In the urban setting, 1124 individuals from 416 households were eligible and 930/1124 (82.7%) consented and provided data. One sub-ward was a military facility and could not be surveyed because the study team was not granted access. In both surveys, the main reasons for non-participation were absenteeism (180/2167;8.3% in the rural setting and 165/1124;14.7% in the urban setting) and refusal (80/2167;3.7% in the rural setting and 18/1124;1.6% in the urban setting). Individual-level demographic data and survey responses are available as *Underlying data* ^[@ref-26]^.

![Study flow chart.](wellcomeopenres-5-17864-g0001){#f2}

Descriptive data
----------------

The characteristics of the study participants are shown in [Table 1](#T1){ref-type="table"}. Male participants constituted approximately half (51%; 1010/1890) and 35% (322/920) of the participants in the rural and urban survey respectively. The mean age of the participants was 31.5 years in the rural setting and 29.7 years in the urban setting. In the rural survey, the main economic activity was fishing (739/1898;37.9%) while in the urban setting most participants were involved in service provision, were artisans or had shops and salons (211/917;23.9%). The rural population was more physically active with 49.3% (920/1868) reporting exercise or vigorous physical activity at least once a week compared to 16.6% (152/914) in the urban setting. More participants in the rural setting reported having ever smoked (343/1868;18.3% vs 38/914;4.2%) or taken alcohol (905/1868;47.5% vs 187/914;20.5%) compared to those in the urban setting.

###### Characteristics of participants in the rural and urban settings.

  ----------------------------------------------------------------------------------------------------------------------------
  Household-level characteristics                    Rural setting\     Urban\           P\
                                                     n/N (%)            setting\         value [\*](#TFN1){ref-type="other"}
                                                                        n/N (%)          
  -------------------------------------------------- ------------------ ---------------- -------------------------------------
  Total number of households participating in\       1271               416              
  the survey                                                                             

  Household size (median, IQR)                       2 (1,3)            4 (2,5)          

  **Individual-level characteristics**                                                   

  Sex, male                                          1010/1898 (51.2)   322/920 (35.0)   \<0.001

  Age                                                                                    

  Age in years (mean, SD)                            31.5 (11.0)        29.7 (15.0)      0.003

  Age in years, grouped                                                                  

              10--19                                 215/1898 (11.8)    261/920 (28.4)   \<0.001

              20--29                                 648/1898 (33.7)    298/920 (32.4)   

              30--39                                 594/1898 (30.7)    164/920 (17.8)   

              40+                                    441/1898 (23.7)    197/920 (21.4)   

  Occupation                                                                             

              Child/student                          121/1898 (7.2)     253/917 (27.6)   \<0.001

              Housewife                              199/1898 (9.7)     166/917 (18.0)   

              Fishing or lake related                739/1898 (37.9)    17/917 (1.9)     

              Shops, salons, artisans, service\      214/1898 (13.0)    211/917 (23.9)   
  providers                                                                              

              Bars, restaurants, food providers,\    160/1898 (8.4)     48/917 (5.2)     
  entertainment                                                                          

              Agriculture, lumbering, charcoal       396/1898 (19.2)    35/917 (3.8)     

              Professional                           33/1898 (2.3)      37/917 (4.0)     

              Unemployed                             36/1898 (2.4)      128/917 (14.0)   

              Other (not specified)                  0                  22/917 (2.4)     

  Residence                                                                              

  Always lived in the study area                     164/1898 (8.6)     454/919 (49.4)   \<0.001

  Place of birth                                                                         

              Village                                1716/1898 (90.2)   318/918 (34.6)   \<0.001

              Town or city                           182/1898 (9.8)     600/918 (65.4)   

  First five years                                                                       

              Village                                1700/1885 (89.8)   339/918 (36.9)   \<0.001

              Town or city                           185/1885 (10.2)    579/918 (63.1)   

  Age of participant when he/she moved to this\      23.0 (11.2)        22.8 (11.3)      0.388
  village (mean, SD)                                                                     

  Parental tribe                                                                         

  Maternal tribe region of origin                                                        

              Central                                678/1898 (36.7)    400/918 (43.5)   0.097

              Western                                294/1898 (15.3)    190/918 (20.7)   

              Eastern                                405/1898 (21.0)    131/918 (14.3)   

              Northern                               202/1898 (10.1)    110/918 (12.0)   

              Non-Ugandan                            311/1898 (16.6)    81/918 (8.8)     

              Do not know                            8/1898 (0.4)       6/918 (0.7)      

  Paternal tribe region of origin                                                        

              Central                                751/1898 (39.1)    404/918 (44.0)   0.202

              Western                                328/1898 (17.6)    172/918 (18.7)   

              Eastern                                385/1898 (20.6)    152/918 (16.6)   

              Northern                               201/1898 (10.3)    115/918 (12.5)   

              Non-Ugandan                            230/1898 (12.2)    71/918 (7.7)     

              Do not know                            3/1898 (0.2)       4/918 (0.4)      

  Treatment for worms                                                                    

  Ever treated for worms                             1661/1896 (86.9)   646/888 (72.8)   \<0.001

  Treated with albendazole in the last 12 months     1301/1597 (82.1)   480/641 (74.9)   0.666

  Treated with praziquantel in the last 12\          1113/1604 (67.2)   19/639 (3.0)     \<0.001
  months                                                                                 

  Lake contact                                                                           

  Frequency of lake contact                                                              

              Every day                              1309/1857 (67.5)   30/916 (3.3)     \<0.001

              Almost every day                       297/1857 (16.3)    36/916 (3.9)     

              Once a week                            192/1857 (11.9)    44/916 (4.8)     

              Once a month                           52/1857 (3.8)      120/916 (13.1)   

              Less than once a month                 7/1857 (0.6)       686/916 (74.9)   

  Diabetes                                                                               

  History of diabetes                                                                    

              Yes                                    7/1868 (0.5)       26/914 (2.8)     \<0.001

              No                                     1841/1868 (98.7)   808/914 (88.4)   

              Do not know                            20/1868 (0.9)      80/914 (8.8)     

  Hypertension                                                                           

  History of hypertension                                                                

              Yes                                    44/1868 (3.0)      77/914 (8.4)     \<0.001

              No                                     1815/1868 (96.5)   811/914 (88.7)   

              Do not know                            9/1868 (0.5)       26/914 (2.8)     

  Exercise                                                                               

  How often do you exercise / participate in\                                            
  vigorous physical activity                                                             

              Every day                              28/1868 (1.4)      11/914 (1.2)     \<0.001

              Almost every day                       396/1868 (21.1)    53/914 (5.8)     

              Once a week                            496/1868 (27.3)    88/914 (9.6)     

              Once a month                           372/1868 (18.7)    90/914 (9.9)     

              Less than once a month                 576/1868 (31.5)    672/914 (73.5)   

  History of smoking and alcohol intake                                                  

  Ever smoked (either pipe or cigarette)             343/1868 (18.3)    38/914 (4.2)     \<0.001

  Ever taken alcohol                                 905/1868 (47.5)    187/914 (20.5)   \<0.001

  Helminth infections                                                                    

  *Schistosoma mansoni*, stool Kato Katz             440/1505 (31.7)    76/770 (9.9)     \<0.001

  *Schistosoma mansoni* intensity, stool Kato Katz                                       

  Uninfected                                         1065/1505 (68.3)   694/770 (90.1)   \<0.001

  Light                                              230/1505 (16.6)    36/770 (4.7)     

  Moderate                                           121/1505 (8.6)     27/770 (3.5)     

  Heavy                                              89/1505 (6.5)      13/770 (1.7)     

  *Schistosoma mansoni*, stool PCR                   694/1487 (47.6)    171/771 (22.2)   \<0.001

  Hookworm, stool Kato Katz                          39/1505 (2.4)      25/769 (3.3)     0.308

  Hookworm, stool PCR                                55/1364 (3.7)      43/771 (5.6)     0.145

  *Trichuris trichiura,* stool Kato Katz             122/1505 (6.9)     17/770 (2.2)     0.002

  *Ascaris lumbricoides,* stool Kato Katz            3/1505 (0.2)       0                \-

  *Mansonella perstans,* modified Knott's            20/1677 (1.1)      3/918 (0.3)      0.143

  *Strongyloides stercoralis,* stool PCR             101/1486 (6.1)     25/771 (3.2)     0.026
  ----------------------------------------------------------------------------------------------------------------------------

Percentages adjusted for survey design; \*P values obtained from survey design-based regression.

The rural participants had more exposure to the lake with 67.5% (1309/1857) reporting daily lake contact compared to only 3.3% (30/916) in the urban setting. Regarding anthelminthic treatment, 86.9% (1661/1896) of participants in the rural setting reported having ever received treatment for worms compared to 72.8% (646/888) of urban participants. Of these, 67.2% (1113/1604) in the rural setting reported having been treated with praziquantel in the last 12 months compared to 3.0% (19/639) in the urban setting. Helminth prevalence was higher in the rural setting with a significantly higher prevalence of *S. mansoni* (stool Kato Katz, 31.7% vs 9.9%, p\<0.001; stool PCR 47.6% vs 22.2%, p\<0.001), *Trichuris trichiura* (stool Kato Katz, 6.9% vs 2.2%, p=0.002) and *Strongyloides stercoralis* (stool PCR, 6.1% vs 3.2%, p=0.026). In both settings, most of the *S. mansoni* infections were of light intensity.

Rural-urban differences in metabolic outcomes
---------------------------------------------

The metabolic outcomes measured in both settings are shown in [Table 2](#T2){ref-type="table"}. Mean fasting glucose was higher in the rural setting than in the urban setting (4.81 vs 4.71 mmol/L; adjusted mean difference -0.26 \[95% confidence interval -0.40, -0.11\] p=0.001). In unadjusted analyses and following adjustment for age and sex, no differences were seen in HOMA-IR. However, after further adjustment for BMI, exercise, alcohol intake and smoking, there was a negative mean difference suggesting higher HOMA-IR in the rural setting. The mean difference was most altered by adjusting for BMI. Following inclusion of HOMA-B as an additional outcome at the suggestion of a review, we found that individuals in the rural setting had lower (worse) pancreatic beta cell function than individuals in the urban setting even after adjusting for age, sex, exercise, alcohol intake, smoking and BMI (141.34 vs 201.72; 40.36 \[8.00, 72.72\] p=0.02\].

###### Comparison of metabolic outcomes in the urban and rural settings.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome                       Mean       Crude\             P-value               [\*](#TFN2){ref-type="other"}Adjusted\   [\*](#TFN2){ref-type="other"}P-value   [\*\*](#TFN2){ref-type="other"}Adjusted\   [\*\*](#TFN2){ref-type="other"}P-value   
                                           mean difference\                         mean difference\                                                                mean difference\                                                                    
                                           (95% CI)                                 (95% CI)                                                                        (95% CI)                                                                            
  ----------------------------- ---------- ------------------ --------------------- ---------------------------------------- -------------------------------------- ------------------------------------------ ---------------------------------------- -------------
  HOMA -- IR                    GM 1.86    GM 2.40            0.08 (-0.07, 0.23)    0.28                                     -0.02 (-0.16, 0.13)                    0.79                                       **-0.18 (-0.32, -0.05)**                 **0.01**

  Fasting glucose (mmol/L)      4.81       4.71               -0.10 (-0.20, 0.00)   0.05                                     -0.10 (-0.20, 0.01)                    0.06                                       **-0.26 (-0.40, -0.11)**                 **0.001**

  Fasting insulin ( *µ*U/ml)    GM 66.99   GM 87.26           0.12 (-0.03, 0.26)    0.11                                     0.01 (-0.12, 0.15)                     0.84                                       -0.12 (-0.25, 0.01)                      0.06

  Triglycerides (mmol/L)        1.10       1.16               0.07 (-0.05, 0.19)    0.27                                     0.10 (-0.03, 0.22)                     0.12                                       0.10 (-0.03, 0.23)                       0.12

  Total cholesterol (mmol/L)    4.48       4.58               0.10 (-0.21, 0.40)    0.53                                     0.12 (-0.18, 0.41)                     0.42                                       0.15 (-0.14, 0.44)                       0.31

  LDL -- Cholesterol (mmol/L)   2.66       2.85               0.19 (-0.22, 0.60)    0.35                                     0.19 (-0.22, 0.60)                     0.35                                       0.21 (-0.27, 0.70)                       0.37

  HDL -- Cholesterol (mmol/L)   1.42       1.31               -0.11 (-0.35, 0.12)   0.34                                     -0.10 (-0.33, 0.13)                    0.38                                       -0.07 (-0.37, 0.23)                      0.63

  Systolic blood pressure\      114.21     117.28             3.07 (1.60, 4.53)     \<0.001                                  **5.66 (4.35, 6.96)**                  **\<0.001**                                **5.45 (3.75, 7.15)**                    **\<0.001**
  (mmHg)                                                                                                                                                                                                                                                

  Diastolic blood pressure\     75.81      76.49              0.67 (-0.45, 1.80)    0.24                                     **2.23 (1.26, 3.21)**                  **\<0.001**                                **1.93 (0.57, 3.29)**                    **0.006**
  (mmHg)                                                                                                                                                                                                                                                

  Body mass index (kg/m2)       23.40      23.83              0.43 (-0.12, 0.97)    0.12                                     **0.81 (0.40, 1.23)**                  **\<0.001**                                **1.07 (0.59, 1.54)**                    **\<0.001**

  Waist circumference (cm)      80.44      78.95              -1.49 (-3.42, 0.43)   0.13                                     0.24 (-1.35, 1.82)                     0.77                                       0.24 (-1.71, 2.19)                       0.81

  Waist-hip Ratio               GM 0.68    GM 0.71            0.02 (-0.01, 0.05)    0.26                                     0.02 (-0.01, 0.05)                     0.11                                       0.03 (-0.01, 0.06)                       0.17
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HOMA-IR, Homeostatic model assessment of insulin resistance; GM, geometric means; P values obtained from survey design-based linear regression; \*Adjusted for age and sex; \*\*Adjusted for age, sex, occupation, exercise, alcohol intake and smoking; HOMA-IR, fasting glucose, triglycerides, LDL-cholesterol, HDL-cholesterol, systolic and diastolic BP were additionally adjusted for BMI.

Participants in the rural setting had significantly lower mean blood pressure than those in the urban setting even after adjustment for sex, age, exercise, alcohol, smoking and BMI (systolic blood pressure, 114.21 vs 117.28 mmHg 5.45 \[3.75, 7.15\] p\<0.001; diastolic blood pressure 75.81 vs 76.49 mmHg, 1.93 \[0.57, 3.29\] p=0.006). These differences in blood pressure were more marked in the older age groups ( [Figure 3](#f3){ref-type="fig"}).

![Variation of mean systolic and diastolic blood pressure with age in the rural and urban settings.\
The shaded areas represent 95% confidence intervals (allowing for clustering) around the mean systolic and diastolic blood pressure measurements for each age group.](wellcomeopenres-5-17864-g0002){#f3}

Participants in the rural setting had lower mean BMI than those in the urban setting. No differences were observed for waist circumference, waist-hip ratio, triglycerides, total cholesterol, LDL-cholesterol or HDL-cholesterol.

Despite having, on average, higher fasting glucose in the rural setting, there was no difference in the prevalence of diabetes between the rural and urban settings after adjusting for multiple potential confounders. However, the rural setting had a lower prevalence of hypertension (9.1% vs 13.4%, p=0.01) and obesity (7.7% vs 14.0%, p\<0.001), than the urban setting ( [Table 3](#T3){ref-type="table"} and [Table 4](#T4){ref-type="table"}).

###### Comparison of metabolic outcomes by disease categories.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome                                                  n/N (%)           Crude\                 P-value             [\*](#TFN3){ref-type="other"}Adjusted\   [\*](#TFN3){ref-type="other"}P-value   [\*\*](#TFN3){ref-type="other"}Adjusted\   [\*\*](#TFN3){ref-type="other"}P-value   
                                                                             odds ratios (95% CI)                       odds ratios (95% CI)                                                            odds ratios (95% CI)                                                                
  -------------------------------------------------------- ----------------- ---------------------- ------------------- ---------------------------------------- -------------------------------------- ------------------------------------------ ---------------------------------------- -------------
  Diabetes (FBG ≥ 7 mmol/l)                                16/1681 (1.0)     22/902 (2.4)           2.41 (1.32, 4.40)   0.01                                     **2.45 (1.31, 4.58)**                  **0.01**                                   1.84 (0.79, 4.27)                        0.15

  Impaired fasting glucose (FBG 6.1 --\                    35/1681 (1.9)     14/902 (1.6)           0.84 (0.39, 1.81)   0.66                                     0.92 (0.42, 2.06)                      0.84                                       1.05 (0.42, 2.63)                        0.92
  6.9 mmol/l)                                                                                                                                                                                                                                                                               

  Hypertension [\*\*\*](#TFN3){ref-type="other"}           156/1813 (9.1)    123/916 (13.4)         1.60 (1.14, 2.25)   0.01                                     **2.36 (1.67, 3.34)**                  **\<0.001**                                **1.81 (1.15, 2.83)**                    **0.01**

  Prehypertension                                          574/1813 (30.7)   285/916 (31.1)         1.10 (0.89, 1.36)   0.36                                     **1.58 (1.26, 1.98)**                  **\<0.001**                                **1.64 (1.16, 2.33)**                    **0.01**

  Obese (BMI ≥ 30)                                         128/1815 (7.7)    130/ 926 (14.0)        2.34 (1.70, 3.22)   \<0.001                                  **2.28 (1.60, 3.23)**                  **\<0.001**                                **2.36 (1.55, 3.60)**                    **\<0.001**

  Overweight (BMI 25.0 -- 29.9)                            349/1815 (19.9)   188/ 926 (20.3)        1.30 (0.99, 1.70)   0.06                                     1.33 (1.00, 1.77)                      0.05                                       1.45 (0.96, 2.17)                        0.08

  Underweight (BMI \<18.5)                                 119/1815 (7.0)    132/ 926 (14.3)        2.61 (1.72, 3.96)   \<0.001                                  **1.54 (1.04, 2.29)**                  **0.03**                                   1.00 (0.56, 1.78)                        0.99

  Central (abdominal) obesity\                             511/1813 (29.7)   321/925 (34.7)         1.26 (0.94, 1.68)   0.12                                     1.15 (0.83, 1.59)                      0.38                                       1.32 (0.86, 2.04)                        0.20
  (WC≥94cm males, WC ≥80cm females)                                                                                                                                                                                                                                                         

  Central (abdominal) obesity (WHR\>0.9\                   505/1813 (27.8)   227/925 (24.5)         0.84 (0.63, 1.12)   0.24                                     0.75 (0.55, 1.02)                      0.06                                       0.74 (0.53, 1.03)                        0.08
  males, WHR\>0.85 females)                                                                                                                                                                                                                                                                 

  Metabolic Syndrome [\*\*\*\*](#TFN3){ref-type="other"}   109/1675 (6.4)    77/908 (8.5)           1.37 (0.88, 2.13)   0.16                                     1.30 (0.83, 2.04)                      0.24                                       0.74 (0.53, 1.03)                        0.08
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

FBG, Fasting Blood Glucose; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; BMI, Body Mass Index; WC, Waist Circumference; WHR, Waist Hip Ratio; \*Adjusted for age and sex; P values obtained from survey design-based logistic regression; \*\*Adjusted for age, sex, occupation, exercise, alcohol intake and smoking; diabetes, impaired fasting glucose, hypertension and prehypertension were additionally adjusted for BMI; \*\*\* SBP ≥ 140mmHg or DBP ≥ 90mmHg for adults; Blood pressure ≥90 ^th^ percentile for participants aged 10--17 years; \*\*\*\*Any three of: Central obesity \[WC≥94cm males WC ≥80cm Females\], FBG\>5.55, \[SBP≥130 or DBP≥85\], Elevated Triglycerides \[≥1.7 mmol/L\], Reduced HDL -- Cholesterol \[\<1 mmol/L Males, \<1.3 mmol/L females.

###### Comparison of metabolic outcomes by disease categories in adult participants (aged ≥18 years).

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome                                               n/N (%)           Crude\                 P-value             [\*](#TFN4){ref-type="other"}Adjusted\   [\*](#TFN4){ref-type="other"}P-value   
                                                                          odds ratios (95% CI)                       odds ratios (95%\                                                               
                                                                                                                     CI)                                                                             
  ----------------------------------------------------- ----------------- ---------------------- ------------------- ---------------------------------------- -------------------------------------- -------------
  Diabetes (FBG ≥ 7 mmol/l)                             16/1551 (1.1)     21/716 (2.9)           2.66 (1.45, 4.89)   0.002                                    **2.34 (1.24, 4.40)**                  **0.01**

  Impaired fasting glucose (FBG 6.1 -- 6.9 mmol/l)      33/1551 (1.9)     12/716 (1.7)           0.89 (0.40, 2.01)   0.78                                     0.94 (0.41, 2.13)                      0.87

  Hypertension [\*\*](#TFN4){ref-type="other"}          152/1678 (9.5)    116/727 (16.0)         2.01 (1.46, 2.77)   \<0.001                                  **2.62 (1.86, 3.69)**                  **\<0.001**

  Obese (BMI ≥ 30)                                      127/1679 (8.3)    128/732 (17.5)         2.64 (1.92, 3.64)   \<0.001                                  **2.31 (1.64, 3.26)**                  **\<0.001**

  Overweight (BMI 25.0 -- 29.9)                         346/1679 (21.4)   177/732 (24.2)         1.41 (1.08, 1.84)   0.01                                     1.32 (1.00, 1.74)                      0.05

  Underweight (BMI \<18.5)                              51/1679 (3.2)     33/732 (4.5)           1.73 (0.96, 3.14)   0.07                                     1.90 (1.08, 3.36)                      0.03

  Central (abdominal) obesity (WC≥94cm males,\          505/1677 (31.9)   310/731 (42.4)         1.57 (1.17, 2.13)   0.004                                    1.18 (0.85, 1.63)                      0.32
  WC ≥80cm females)                                                                                                                                                                                  

  Central (abdominal) obesity (WHR\>0.9 males,\         471/1677 (28.2)   202/731 (27.6)         0.97 (0.73, 1.29)   0.85                                     0.80 (0.59, 1.08)                      0.14
  WHR\>0.85 females)                                                                                                                                                                                 

  [\*\*\*](#TFN4){ref-type="other"}Metabolic Syndrome   108/1547 (6.9)    76/719 (10.6)          1.59 (1.04, 2.44)   0.03                                     1.30 (0.84, 2.02)                      0.24
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

FBG, Fasting Blood Glucose; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; BMI, Body Mass Index; WC, Waist Circumference; WHR, Waist Hip Ratio; \*Adjusted for age and sex; P values obtained from survey design-based logistic regression; \*\* SBP ≥ 140mmHg or DBP ≥ 90mmHg for adults; Blood pressure ≥90 ^th^ percentile for participants aged 10--17 years; \*\*\*Any three of: Central obesity \[WC≥94cm males WC ≥80cm Females\], FBG\>5.55, \[SBP≥130 or DBP≥85\], Elevated Triglycerides \[≥1.7 mmol/L\], Reduced HDL -- Cholesterol \[\<1 mmol/L Males, \<1.3 mmol/L females.

Helminth infection and intensity did not explain the rural urban differences observed for the metabolic parameters: very little change was seen in the mean differences after further adjustment for helminth infection status or helminth infection intensity ( [Table 5](#T5){ref-type="table"}).

###### Effect of adjusting for helminths on differences in metabolic outcomes.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome                               Mean      Crude\             P-value               [\*](#TFN5){ref-type="other"}Adjusted\   [\*](#TFN5){ref-type="other"}P-\   [\*\*](#TFN5){ref-type="other"}Adjusted\   [\*\*](#TFN5){ref-type="other"}P-\   
                                                  mean difference\                         mean difference\                         value                              mean difference\                           value                                
                                                  (95% CI)                                 (95% CI)                                                                    (95% CI)                                                                        
  ------------------------------------- --------- ------------------ --------------------- ---------------------------------------- ---------------------------------- ------------------------------------------ ------------------------------------ ----------
  **HOMA -- IR**                        GM 1.86   GM 2.40            0.08 (-0.07, 0.23)    0.28                                     -0.02 (-0.16, 0.13)                0.79                                       **-0.13 (-0.25, -0.01)**             **0.04**

  With each helminth included in\                                                                                                                                                                                                                      
  the model                                                                                                                                                                                                                                            

  *S. mansoni* KK (n=2092)                                           0.07 (-0.08, 0.21)    0.38                                     -0.01 (-0.15, 0.14)                0.95                                       -0.12 (-0.25, 0.02)                  0.09

  *S. mansoni* PCR (n=2077)                                          0.05 (-0.10, 0.19)    0.54                                     -0.03 (-0.17, 0.11)                0.70                                       -0.13 (-0.25, 0 .00)                 0.06

  *S. mansoni* intensity KK (n=2092)                                 0.07 (-0.08, 0.21)    0.37                                     0.00 (-0.15, 0.14)                 0.97                                       -0.11 (-0.24, 0.02)                  0.09

  *T. trichiura* KK (n=2092)                                         0.08 (-0.07, 0.22)    0.32                                     -0.02 (-0.16, 0.13)                0.82                                       -0.12 (-0.25, 0.01)                  0.07

  Hookworm PCR (n=1962)                                              0.07 (-0.08, 0.22)    0.33                                     -0.02 (-0.16, 0.13)                0.82                                       -0.12 (-0.25, 0.02)                  0.08

  *S. stercoralis* PCR (n=2076)                                      0.06 (-0.09, 0.21)    0.41                                     -0.02 (-0.17, 0.13)                0.78                                       -0.12 (-0.26, 0.01)                  0.06

  Any worm (n=2028)                                                  0.05 (-0.10, 0.19)    0.54                                     -0.03 (-0.17, 0.11)                0.66                                       -0.13 (-0.25, 0.00)                  0.05

  **Fasting glucose (mmol/L)**          4.81      4.71               -0.10 (-0.20, 0.00)   0.05                                     -0.10 (-0.20, 0.01)                0.06                                       **-0.13 (-0.24, -0.01)**             **0.04**

  With each helminth included in the\                                                                                                                                                                                                                  
  model                                                                                                                                                                                                                                                

  *S. mansoni* KK (n= 2109)                                          -0.10 (-0.22, 0.02)   0.09                                     -0.07 (-0.19, 0.04)                0.21                                       -0.11 (-0.23, 0.02)                  0.08

  *S. mansoni* PCR (n=2094)                                          -0.12 (-0.24, 0.00)   0.05                                     -0.10 (-0.21, 0.02)                0.11                                       -0.13 (-0.25, 0.00)                  0.04

  *S. mansoni* intensity KK (n=2109)                                 -0.10 (-0.22, 0.02)   0.10                                     -0.07 (-0.19, 0.04)                0.22                                       -0.11 (-0.23, 0.02)                  0.09

  *T. trichiura* KK (n=2109)                                         -0.08 (-0.19, 0.03)   0.14                                     -0.08 (-0.19, 0.03)                0.17                                       -0.11 (-0.23, 0.01)                  0.07

  Hookworm PCR (n=1979)                                              -0.08 (-0.19, 0.03)   0.15                                     -0.07 (-0.18, 0.04)                0.20                                       -0.11 (-0.23, 0.02)                  0.09

  *S. stercoralis* PCR (n=2093)                                      -0.08 (-0.19, 0.04)   0.194                                    -0.07 (-0.19, 0.04)                0.20                                       -0.11 (-0.23, 0.02)                  0.09

  Any worm (n=2045)                                                  -0.12 (-0.25, 0.01)   0.06                                     -0.10 (-0.22, 0.03)                0.12                                       -0.13 (-0.26, 0.00)                  0.05

  **Systolic blood pressure (mmHg)**    114.21    117.28             3.07 (1.60, 4.53)     \<0.001                                  5.66 (4.35, 6.96)                  \<0.001                                    4.64 (3.23, 6.06)                    \<0.001

  With each helminth included in the\                                                                                                                                                                                                                  
  model                                                                                                                                                                                                                                                

  *S. mansoni* KK (n=2187)                                           3.47 (1.93, 5.01)     \<0.001                                  5.94 (4.51, 7.38)                  \<0.001                                    4.66 (2.93, 6.39)                    \<0.001

  *S. mansoni* PCR (n=2172)                                          3.45 (1.99, 4.92)     \<0.001                                  5.82 (4.58, 7.06)                  \<0.001                                    4.67 (3.16, 6.19)                    \<0.001

  *S. mansoni* intensity KK (n=2187)                                 3.47 (1.95, 5.00)     \<0.001                                  5.94 (4.53, 7.36)                  \<0.001                                    4.65 (2.96, 6.34)                    \<0.001

  *T. trichiura* KK (n=2187)                                         3.10 (1.75, 4.45)     \<0.001                                  5.65 (4.37, 6.92)                  \<0.001                                    4.45 (2.89, 6.00)                    \<0.001

  Hookworm PCR (n=2054)                                              3.42 (1.98, 4.86)     \<0.001                                  5.88 (4.58, 7.18)                  \<0.001                                    4.64 (3.11, 6.18)                    \<0.001

  *S. stercoralis* PCR (n=2171)                                      3.49 (2.10, 4.89)     \<0.001                                  5.83 (4.55, 7.11)                  \<0.001                                    4.65 (3.13, 6.18)                    \<0.001

  Any worm (n=2122)                                                  3.30 (1.90, 4.70)     \<0.001                                  5.71 (4.49, 6.92)                  \<0.001                                    4.53 (3.04, 6.03)                    \<0.001

  **Diastolic blood pressure (mmHg)**   75.81     76.49              0.67 (-0.45, 1.80)    0.24                                     2.23 (1.26, 3.21)                  \<0.001                                    1.89 (0.81, 2.97)                    0.001

  With each helminth included in\                                                                                                                                                                                                                      
  the model                                                                                                                                                                                                                                            

  *S. mansoni* KK (n=2187)                                           0.34 (-0.84, 1.51)    0.567                                    2.17 (1.15, 3.18)                  \<0.001                                    1.71 (0.59, 2.84)                    0.004

  *S. mansoni* PCR (n=2172)                                          0.38 (-0.72, 1.48)    0.492                                    2.10 (1.15, 3.05)                  \<0.001                                    1.73 (0.65, 2.80)                    0.002

  *S. mansoni* intensity KK (n=2187)                                 0.32 (-0.88, 1.51)    0.596                                    2.15 (1.11, 3.18)                  \<0.001                                    1.67 (0.54, 2.80)                    0.005

  *T. trichiura* KK (n=2187)                                         0.35 (-0.84, 1.54)    0.554                                    1.97 (0.97, 2.97)                  \<0.001                                    1.55 (0.46, 2.63)                    0.006

  Hookworm PCR (n=2054)                                              0.51 (-0.66, 1.69)    0.385                                    2.08 (1.07, 3.09)                  \<0.001                                    1.70 (0.59, 2.80)                    0.003

  *S. stercoralis* PCR (n=2171)                                      0.57 (-0.60, 1.74)    0.330                                    2.08 (1.08, 3.08)                  \<0.001                                    1.71 (0.60, 2.82)                    0.003

  Any worm (n=2122)                                                  0.29 (-0.79, 1.36)    0.592                                    2.00 (1.06, 2.94)                  \<0.001                                    1.62 (0.59, 2.65)                    0.003

  **Body mass index (kg/m2)**           23.40     23.83              0.43 (-0.12, 0.97)    0.12                                     0.81 (0.40, 1.23)                  \<0.001                                    0.60 (0.10, 1.10)                    0.020

  With each helminth included in the\                                                                                                                                                                                                                  
  model                                                                                                                                                                                                                                                

  *S. mansoni* KK (n=2158)                                           0.19 (-0.38, 0.76)    0.499                                    0.88 (0.43, 1.34)                  \<0.001                                    0.71 (0.11, 1.31)                    0.021

  *S. mansoni* PCR (n=2143)                                          0.18 (-0.40, 0.76)    0.535                                    0.80 (0.31, 1.29)                  0.002                                      0.64 (0.01, 1.27)                    0.046

  *S. mansoni* intensity KK (n=2158)                                 0.20 (-0.38, 0.77)    0.496                                    0.89 (0.43, 1.35)                  \<0.001                                    0.72 (0.11, 1.32)                    0.022

  *T. trichiura* KK (n=2158)                                         0.39 (-0.17, 0.95)    0.166                                    0.81 (0.37, 1.25)                  0.001                                      0.64 (0.06, 1.22)                    0.032

  Hookworm PCR (n=2027)                                              0.48 (-0.09, 1.05)    0.094                                    0.87 (0.41, 1.34)                  \<0.001                                    0.73 (0.14, 1.33)                    0.017

  *S. stercoralis* PCR (n=2142)                                      0.43 (-0.14, 1.00)    0.136                                    0.83 (0.37, 1.29)                  0.001                                      0.67 (0.09, 1.25)                    0.024

  Any worm (n=2094)                                                  0.23 (-0.35, 0.81)    0.436                                    0.81 (0.34, 1.28)                  0.001                                      0.67 (0.06, 1.28)                    0.033
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HOMA-IR, Homeostatic model assessment of insulin resistance; GM, geometric means; P values obtained from survey design-based linear regression; \*Adjusted for age and sex: \*\*Adjusted for age, sex, exercise, alcohol intake and smoking; HOMA-IR, fasting glucose, triglycerides, LDL-cholesterol, HDL-cholesterol, systolic and diastolic BP were additionally adjusted for BMI.

Discussion
==========

In this paper, we have shown that individuals in a rural, high helminth transmission setting had higher mean HOMA-IR and fasting glucose, and lower pancreatic beta cell function than those in an urban low helminth transmission setting. They also had substantially lower blood pressure and BMI than their urban counterparts. This was not explained by differences in activity levels, age or sex or (for blood pressure) BMI and we did not find any impact of helminth infection on the observed rural-urban differences.

In our relatively young study population, the prevalence of diabetes was low in both settings. It was surprising to find a higher mean fasting glucose and insulin resistance and lower pancreatic beta cell function in the rural setting. Although a higher diabetes prevalence in a rural setting compared to the urban setting has been reported in a study among secondary school students in Cameroon, there was no significant difference in mean fasting glucose in that study ^[@ref-35]^. One possible explanation for our finding is occupational. The majority of our rural population is involved in fishing and fishing is mainly conducted at night. Night shift work has been associated with changes in the diurnal pattern of cortisol and consequently predicts increased concentrations of cortisol ^[@ref-36]^. Higher cortisol levels have been associated with raised plasma glucose and insulin resistance ^[@ref-37],\ [@ref-38]^. Shift work has been linked to an increased risk of diabetes ^[@ref-39]^, therefore, it is important to study how night time work in these rural fishing communities impacts metabolic health. Also, in view of their occupation, we cannot rule out the possibility that individuals in the rural setting were less adherent to the instructions on overnight fasting before the blood draw.

Another possible explanation is derived from the "thrifty phenotype hypothesis", which proposes a link between poor fetal and early postnatal nutrition, and the development of T2D in adulthood ^[@ref-40]^. This hypothesis proposes that malnutrition in early life impedes development of the pancreas making the pancreas more susceptible to development of diabetes. Therefore, individuals who have spent their early life in rural areas (as most of the rural survey participants had done in this study), where undernutrition is more common, are more prone to glucose dysregulation.

The prevalence of hypertension was low in both settings. The rural environment was protective against hypertension, as suggested by the lower mean blood pressure and lower hypertension prevalence. This is in agreement with previous findings in Uganda and the region ^[@ref-41],\ [@ref-42]^. Taking into account the higher levels of physical activity and lower BMI among the rural participants in our study did not alter the result, neither did adjusting for smoking and alcohol intake. This implies that other protective factors associated with the rural environment, not measured in our study, such as lower sodium intake ^[@ref-43]^ and less pollution could be responsible for this. However, modernisation and change in household income may overturn the protective effects of the rural environment. For example, sodium intake in rural and urban Malawi is higher than the recommended amounts ^[@ref-44]^. Studies to investigate the trends in cardiometabolic risk factors in rural environments such as the fishing communities we studied are therefore important.

The rural-urban differences we observed in glucose metabolism, blood pressure and BMI could not be explained by the differences in current helminth prevalence. Given the existence of helminth infection in both settings, this is not surprising. The exposure to helminth infection in this particular urban setting (a peninsula, with easy access to the lake) was perhaps not low enough to eliminate helminth effects. Immunological changes induced by helminths can persist for long periods after clearance of the helminths ^[@ref-45]^. Lifestyle factors and other environmental exposures may be having a stronger influence on metabolic outcomes than helminths. However, investigating the role of helminths in the epidemiological transition still remains an important and interesting prospect worth pursuing. Indeed, our previous LaVIISWA trial and observational analyses suggested that schistosomiasis infection was associated with lower serum total cholesterol and LDL-cholesterol levels and that moderate to heavy S. mansoni infection was associated with lower triglycerides, LDL-cholesterol and diastolic blood pressure levels. Intensive anthelminthic treatment resulted in higher LDL-cholesterol levels, although helminths were still present in this intensively treated group, albeit with lower intensity than in residents of villages who received standard anthelminthic treatment ^[@ref-22]^. Further work in an area with lower helminth prevalence is required to investigate this hypothesis.

The strengths of our project include the large sample size and the uniqueness of the study settings in relation to helminth prevalence. However, we were limited by the cross-sectional nature of the study and therefore cannot make causal inferences from the results, and cannot investigate the longevity, in the context of lifestyle and epidemiological changes, of the observed differences. We performed multiple tests and did not formally correct for this, so cannot rule out chance findings, but all analyses were pre-planned and consistency between glucose and HOMA-IR and between diastolic and systolic blood pressure lend weight to the findings. Differences in socioeconomic status and diet were not assessed and it is possible that these might partially explain differences between rural and urban settings. Fishing communities are rather unique rural communities in relation to housing, lifestyle, diet and exposure to schistosomiasis, and may not be representative of all rural communities.

In conclusion, our findings raise important questions about blood glucose and the rural environment. Is the rural environment potentially detrimental to glucose metabolism? Will the source of the next epidemic of diabetes be the rural areas even when the rural environment still remains associated with a better blood pressure and anthropometric profile?

Data availability
=================

Underlying data
---------------

LSHTM Data compass: Contrasting impact of rural, versus urban, living on glucose metabolism and blood pressure in Uganda. <https://doi.org/10.17037/DATA.00001528> ^[@ref-26]^.

This project contains the following underlying data:

-   Rural-urban_survey_data.csv (individual-level rural-urban survey data).

-   Rural-urban_survey_data_codebook.html (codebook for Rural-urban survey data; also lists all questions asked of study participants).

Data are available under the terms of the [Creative Commons Attribution 3.0 International license](https://creativecommons.org/licenses/by/3.0/legalcode) (CC-BY 3.0).
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In the present manuscript, Sanya *et al*. have conducted a cross-sectional study comparing various metabolic parameters in both rural and urban communities in Uganda for investigating the potential impact of helminth infection and living environment on cardiometabolic diseases. Altogether, after multiple adjustments, they found that individuals living in rural environment have a lower blood pressure than urban ones, as previously reported in other studies conducted in different countries, but a surprisingly higher fasting glucose levels and HOMA-IR despite lower incidence of type 2 diabetes. Helminth infection seems not to have any significant impact on all these parameters but, as acknowledged by the authors, individuals living in urban environment have a rather high rates of infection/treatment with anthelmintic drugs, suggesting that previous exposure might have already triggered/imprinted some immune response potentially beneficial for metabolic homeostasis.

The design of the study is solid and the large sample size available, together with subtle diagnosis of helminths infection, is clearly one of the strength of such approach. The main weakness relies on the significant differences in gender and age distribution between rural and urban communities, especially for young participants (\<19 year-old; 11.8% versus 28%, respectively; p\<0.001). I'd have been curious to see whether the main outcomes were still present if the analyses have been systematically done only in adults.

I have some minor comments/questions: I'd suggest reporting the raw data for BMI and fasting insulin levels (used to calculate HOMA-IR) in Table 1 and 2, respectively.To try explaining the counterintuitive higher fasting glucose levels in individuals living in rural environment, the authors suggested that early life malnutrition in such population might affect pancreas development and predispose to metabolic dysfunctions. As such, it would have been interesting to calculate HOMA-B (20 × fasting insulin (μIU/ml)/fasting glucose (mmol/ml) − 3.5), which is a widely used index for assessing pancreatic beta cell function in humans.The discussion around the impact of disturbances in circadian rhythms, notably of cortisol levels, on glucose homeostasis due to nocturnal fishing activities in rural communities is definitely relevant. But it also raises a question about the eventual compliance to fasting for blood collection in such conditions. Could the authors provide a bit more information about the nutritional guidelines provided to the subjects prior to blood collection (last meal, sugar beverages...)? Same thing concerning the moment of the day where the blood pressure was measured.I'm not sure the term "impair glucose metabolism" used in the conclusion of the abstract is the most appropriate since both fasting plasma glucose levels and HOMA-IR, although higher in individuals living in rural than urban areas, are still far from the pathological ranges.

Is the work clearly and accurately presented and does it cite the current literature?

Yes

If applicable, is the statistical analysis and its interpretation appropriate?

I cannot comment. A qualified statistician is required.

Are all the source data underlying the results available to ensure full reproducibility?

Yes

Is the study design appropriate and is the work technically sound?

Yes

Are the conclusions drawn adequately supported by the results?

Yes

Are sufficient details of methods and analysis provided to allow replication by others?

Yes

Reviewer Expertise:

Molecular pathophysiology of metabolic diseases; Immunometabolism.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Sanya

Richard

MRC/UVRI and LSHTM Uganda Research Unit, Uganda

**Competing interests:**No competing interests were disclosed.
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The authors thank the reviewer for the comments on the manuscript and respond as follows.

**Comment:**In the present manuscript, Sanya  *et al*. have conducted a cross-sectional study comparing various metabolic parameters in both rural and urban communities in Uganda for investigating the potential impact of helminth infection and living environment on cardiometabolic diseases. Altogether, after multiple adjustments, they found that individuals living in rural environment have a lower blood pressure than urban ones, as previously reported in other studies conducted in different countries, but a surprisingly higher fasting glucose levels and HOMA-IR despite lower incidence of type 2 diabetes. Helminth infection seems not to have any significant impact on all these parameters but, as acknowledged by the authors, individuals living in urban environment have a rather high rates of infection/treatment with anthelmintic drugs, suggesting that previous exposure might have already triggered/imprinted some immune response potentially beneficial for metabolic homeostasis.

The design of the study is solid and the large sample size available, together with subtle diagnosis of helminths infection, is clearly one of the strength of such approach. The main weakness relies on the significant differences in gender and age distribution between rural and urban communities, especially for young participants (\<19 year-old; 11.8% versus 28%, respectively; p\<0.001). I'd have been curious to see whether the main outcomes were still present if the analyses have been systematically done only in adults.

**Response:** Following the reviewer's suggestion, we did the analysis only in adults ( [table 3](https://s3-eu-west-1.amazonaws.com/wellcomeopenresearch/linked/234033.Table_3.png)) and still found the differences in blood pressure and BMI. However, the differences in fasting glucose and HOMA-IR were less apparent, albeit with wider confidence intervals due to the reduction in sample size.

**Comment:**I have some minor comments/questions: 

**Comment:**I'd suggest reporting the raw data for BMI and fasting insulin levels (used to calculate HOMA-IR) in Table 1 and 2, respectively.

**Response:**Data on the mean BMI in both populations are reported in table 2 and on the weight categories classified according to BMI in table 4. In the revised version of the manuscript, we have included the mean insulin levels in table 2.

**Comment:**To try explaining the counterintuitive higher fasting glucose levels in individuals living in rural environment, the authors suggested that early life malnutrition in such population might affect pancreas development and predispose to metabolic dysfunctions. As such, it would have been interesting to calculate HOMA-B (20 × fasting insulin (μIU/ml)/fasting glucose (mmol/ml) − 3.5), which is a widely used index for assessing pancreatic beta cell function in humans.

**Response:** We calculated the mean pancreatic beta cell function in the two populations using the formula above. We found that individuals in the urban setting had higher (better) pancreatic beta cell function (HOMA-B) than individuals in the rural setting even after adjusting for age, sex, exercise, alcohol intake, smoking and BMI (141.34 vs  201.72; adjusted mean difference 40.36 \[95% confidence interval 8.00, 72.72\] p= 0.02). This has been included in the revised manuscript.

**Comment:**The discussion around the impact of disturbances in circadian rhythms, notably of cortisol levels, on glucose homeostasis due to nocturnal fishing activities in rural communities is definitely relevant. But it also raises a question about the eventual compliance to fasting for blood collection in such conditions. Could the authors provide a bit more information about the nutritional guidelines provided to the subjects prior to blood collection (last meal, sugar beverages...)? Same thing concerning the moment of the day where the blood pressure was measured.

**Response:**The discussion has been revised to include the possibility of non-compliance to overnight fasting. However, all participants were told to fast from food and drink overnight for at least 8 hours and not to exercise or smoke before sample collection in the morning. Plain water could be consumed as much and as often as desired.

**Comment:**I'm not sure the term "impair glucose metabolism" used in the conclusion of the abstract is the most appropriate since both fasting plasma glucose levels and HOMA-IR, although higher in individuals living in rural than urban areas, are still far from the pathological ranges.

**Response:**We have revised the conclusion to reflect this.
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Version 1

This large-scale cross-sectional study compares urban and rural Ugandans in several measures of cardiometabolic health risk. It highlights one salient aspect of many rural environments - intestinal helminthic infections - to test whether having helminths is associated with better cardiometabolic health. This follows from a small but growing literature that has proposed the intriguing hypothesis that helminths might offer protection against insulin resistance, hypercholesterolemia, hypertension and other factors underlying diabetes and atherosclerosis risk. While the authors find urban-rural differences in the majority of health outcomes, they do not find any evidence that helminths mediate these differences.

As the authors indicate, helminth infection is highly prevalent in both rural and urban settings, and so there is no helminth-free control comparison. While helminths do not explain any urban-rural differences in cardiometabolic health, it is possible that helminth infection is still associated with lower blood glucose, lower blood pressure and other health variables -- just that these effects are similar across the urban-rural divide. Those analyses are not reported here. But a prior paper by this same research team working in Uganda (Sanya *et al*. 2019 ^[@rep-ref-38187-1]^) does a better job of directly testing the helminth hypothesis by comparing those who received a standard antihelminth treatment with those receiving a more intensive pharmacological treatment regime. While that paper also did not have a helminth-free control, it did show that more frequent antihelminth treatment resulted in lower LDL and total cholesterol. Having a heavier *Schistosoma mansoni* infectious burden was also associated with lower blood triglyceride levels and lower diastolic blood pressure. It is curious that these rich findings by the same team are not highlighted or contextualized in the current study.

I wonder if the Kato Katz analysis of infection intensity gives any more traction than the binary presence/absence used in the paper. Given most people have low-level burden, is it the case that protective effects are more evident among those with heavier burden? Given the cross-sectional nature of the database, however, those with heavier worm burden may have other health deficits or be living under more resource-poor and compromised setting. Additional controls for socioeconomic status may help adjust for potential confounding.

As for the urban-rural health differences, the authors show that urban areas have higher diabetes risk (but lower fasting blood glucose), and higher prevalence of hypertension and obesity -- though it is worth noting that overall prevalence of these conditions is low in both settings, and that \~77% of their sample consists of people under age 40. Perhaps due to the small absolute differences between setting, they find no urban-rural differences in metabolic syndrome---itself just a combination of the other cardiometabolic biomarkers.

The emphasis on urban-rural health differences is a useful starting point, but itself does not explain much, and may not generalize to other regions or countries. The authors conclude in the Abstract: "In low-income countries, rural living may protect against hypertension but impair glucose metabolism". What is the basis for making such a broad generalization? "Urban" or "rural" are proxies for a cluster of traits that directly impact health, including diet, lifestyle differences (e.g. alcohol, smoking), physical activity, infection, social cohesion, pollution exposure, and the like. In the Ugandan context here, there are some patterns that do not generalize to many other urban-rural comparisons. For example, smoking and alcohol consumption appear to be more common in the rural than the urban context. Underweight is more prevalent in the urban setting, and this urban setting has lower but non-trivial prevalence of infection by several helminth species. These characteristics will vary widely across regions and countries. In order to generalize you would expect to find consistent differences across the key domains relevant to cardiometabolic disease: diet, physical activity, lifestyle, infection, etc.

Given that urban-rural health differences still exist in their fully adjusted models, what can one conclude as to why? The first possibility is what might be missing from the adjusted models. The most obvious missing variable(s) reflect diet. It was a shame that diet was not assessed (or even described in a general way), including additives like sugar, salt and oil, and consumption of processed foods and beverages. Physical activity was also not measured directly, though participants were asked about "exercise and vigorous activity". Exercise may be construed as a bit of a luxury, and vigorous activity is indicative but may not be the most relevant for comparison. What is more telling is how much moderate activity vs. sedentary activity people engage in through their daily activities -- not restricted to leisure or exercise. Even without activity directly measured (e.g. with accelerometry), it's possible that occupation might give a better indication of habitual activity than the interview question on exercise/vigorous activity. Perhaps adjustment for livelihood would contribute towards explaining (at least statistically) the urban-rural health differences.

Another question is how long the current differences between urban and rural contexts have existed? If some lifestyle changes are recent, there might be greater health differences across urban-rural contexts among the younger cohorts. In this case, there would be an interaction between age cohort and urban-rural difference. Similarly, is there a sex difference in exposures due to how modernization manifests? I noticed that the urban sample was much more female-biased, suggesting male out-migration or wage labor leading to greater male absenteeism.

The authors mention the thrifty phenotype as a possible explanation for why people in the rural areas might be prone to glucose dysregulation. Thrifty phenotype and developmental origins of health and disease (DOHaD) paradigms emphasize the effects of early life exposures on later life chronic disease risk, especially when conditions shift over the life course (e.g. from harsh to abundant). That one-third of those living in the urban context were born and spent their first five years of life in a rural area permits one to explore the potential effects of developmental plasticity. A "purer" urban-rural contrast would be limited to those who spent their entire lives in the same environmental context. An additional exploration could test whether those who spent their early life in a rural context but now live in an urban context show worse cardiometabolic health than those who have spent their entire lives in a rural context. The authors have the data to make these comparisons, but do not include these early life variables in any analyses other than sample description (Table 1).

Lastly, while the authors speculate that sleep disruption and altered circadian rhythms might explain the surprising finding that fasting glucose is higher in the rural context, a simpler (but less interesting) possibility is that people in a rural context may be less likely to adhere to the requirement of an overnight fast prior to blood draw (especially if as noted, night fishing is a common activity in the rural setting). In the future, glycosylated hemoglobin (HbA1c) could be measured to provide a more reliable, long-term indicator of glucose levels.

Also, although maybe less relevant, it was unclear whether there are ethnic differences within or between sampling areas that might reflect genetic differences underlying health risk.

Overall, this is a nice epidemiological study highlighting imminent chronic disease risks in Uganda, showcasing that such risks are not restricted to urban areas. Prevalence rates of hypertension and central obesity are noteworthy in both urban and rural contexts.

Minor:

Given lower response rate due to absenteeism in the urban sample, are absent individuals more or less likely to show any health differences than those at home (e.g. more involved in wage labor, and perhaps more integrated into market economy)? If data exist for only one round of data collection then maybe this potential for bias cannot be checked.

Any current use of medications, e.g. for hypertension? If so, are those individuals excluded from analyses of biomarkers?

Is the work clearly and accurately presented and does it cite the current literature?

Yes

If applicable, is the statistical analysis and its interpretation appropriate?

Yes

Are all the source data underlying the results available to ensure full reproducibility?

Yes

Is the study design appropriate and is the work technically sound?

Yes

Are the conclusions drawn adequately supported by the results?

Partly

Are sufficient details of methods and analysis provided to allow replication by others?

Yes

Reviewer Expertise:

Evolutionary anthropology, indigenous health.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Sanya

Richard

MRC/UVRI and LSHTM Uganda Research Unit, Uganda

**Competing interests:**No competing interests were disclosed.
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The authors thank the reviewer for the comments on the manuscript and respond as follows.

**Comment:**This large-scale cross-sectional study compares urban and rural Ugandans in several measures of cardiometabolic health risk. It highlights one salient aspect of many rural environments - intestinal helminthic infections - to test whether having helminths is associated with better cardiometabolic health. This follows from a small but growing literature that has proposed the intriguing hypothesis that helminths might offer protection against insulin resistance, hypercholesterolemia, hypertension and other factors underlying diabetes and atherosclerosis risk. While the authors find urban-rural differences in the majority of health outcomes, they do not find any evidence that helminths mediate these differences.

As the authors indicate, helminth infection is highly prevalent in both rural and urban settings, and so there is no helminth-free control comparison. While helminths do not explain any urban-rural differences in cardiometabolic health, it is possible that helminth infection is still associated with lower blood glucose, lower blood pressure and other health variables -- just that these effects are similar across the urban-rural divide. Those analyses are not reported here. But a prior paper by this same research team working in Uganda (Sanya  *et al*. 2019 [^1^](https://wellcomeopenresearch.org/articles/5-39/v1#rep-ref-38187-1)) does a better job of directly testing the helminth hypothesis by comparing those who received a standard antihelminth treatment with those receiving a more intensive pharmacological treatment regime. While that paper also did not have a helminth-free control, it did show that more frequent antihelminth treatment resulted in lower LDL and total cholesterol. Having a heavier  *Schistosoma mansoni* infectious burden was also associated with lower blood triglyceride levels and lower diastolic blood pressure. It is curious that these rich findings by the same team are not highlighted or contextualized in the current study.

**Response:**Thank you for this suggestion. We agree that helminth infection may still be associated with lower blood glucose and other health variables. Following the reviewer's suggestion, in the new version of the manuscript, we have incorporated our previous findings into the fifth paragraph of the discussion, and highlight that the potential role of helminths in the epidemiological transition merits further investigation.

**Comment:**I wonder if the Kato Katz analysis of infection intensity gives any more traction than the binary presence/absence used in the paper. Given most people have low-level burden, is it the case that protective effects are more evident among those with heavier burden? Given the cross-sectional nature of the database, however, those with heavier worm burden may have other health deficits or be living under more resource-poor and compromised setting. Additional controls for socioeconomic status may help adjust for potential confounding.

**Response:**Thank you for this suggestion. We have redone the analysis and included *S. mansoni* infection intensity in the revised manuscript (Table 5). *S. mansoni* infection intensity did not explain  the rural-urban differences, and we have expanded the text in the last paragraph of the results section to include this finding. Unfortunately, we did not collect data on socio-economic status in the metabolic survey conducted in the rural setting and were therefore unable to adjust for it in this analysis. We now state this in the discussion (paragraph 6) as a limitation of the study.

**Comment:**As for the urban-rural health differences, the authors show that urban areas have higher diabetes risk (but lower fasting blood glucose), and higher prevalence of hypertension and obesity -- though it is worth noting that overall prevalence of these conditions is low in both settings, and that \~77% of their sample consists of people under age 40. Perhaps due to the small absolute differences between setting, they find no urban-rural differences in metabolic syndrome---itself just a combination of the other cardiometabolic biomarkers.

**Response**: Thank you for pointing this out. The overall prevalence of diabetes and hypertension was low in both settings and the majority of the population was young. We have now highlighted the relatively young study population (representative of the country as a whole) in the discussion. We had previously stated in the discussion that the prevalence of diabetes was low in both settings, but have now included a similar statement about hypertension in the revised manuscript.

**Comment:**The emphasis on urban-rural health differences is a useful starting point, but itself does not explain much, and may not generalize to other regions or countries. The authors conclude in the Abstract: "In low-income countries, rural living may protect against hypertension but impair glucose metabolism". What is the basis for making such a broad generalization? "Urban" or "rural" are proxies for a cluster of traits that directly impact health, including diet, lifestyle differences (e.g. alcohol, smoking), physical activity, infection, social cohesion, pollution exposure, and the like. In the Ugandan context here, there are some patterns that do not generalize to many other urban-rural comparisons. For example, smoking and alcohol consumption appear to be more common in the rural than the urban context. Underweight is more prevalent in the urban setting, and this urban setting has lower but non-trivial prevalence of infection by several helminth species. These characteristics will vary widely across regions and countries. In order to generalize you would expect to find consistent differences across the key domains relevant to cardiometabolic disease: diet, physical activity, lifestyle, infection, etc.

**Response:**We appreciate the reviewer's point and have refined the conclusion to make it more specific. It now reads "In the Ugandan context, living in rural fishing communities may protect against hypertension but worsen glucose metabolism".

**Comment:**Given that urban-rural health differences still exist in their fully adjusted models, what can one conclude as to why? The first possibility is what might be missing from the adjusted models. The most obvious missing variable(s) reflect diet. It was a shame that diet was not assessed (or even described in a general way), including additives like sugar, salt and oil, and consumption of processed foods and beverages. Physical activity was also not measured directly, though participants were asked about "exercise and vigorous activity". Exercise may be construed as a bit of a luxury, and vigorous activity is indicative but may not be the most relevant for comparison. What is more telling is how much moderate activity vs. sedentary activity people engage in through their daily activities -- not restricted to leisure or exercise. Even without activity directly measured (e.g. with accelerometry), it's possible that occupation might give a better indication of habitual activity than the interview question on exercise/vigorous activity. Perhaps adjustment for livelihood would contribute towards explaining (at least statistically) the urban-rural health differences.

**Response:**In the second last paragraph of the discussion, we acknowledged the absence of data on diet as a limitation and have stated, in the revised manuscript, that the differences in the rural and urban settings may be partially explained by diet and socio-economic status, and that not being able to adjust for these factors is a limitation of the study. Following the reviewer's suggestion, we have redone the analysis and added occupation as a possible proxy for activity levels to the adjusted models. No major differences were observed between the findings from the adjusted model and those in the previous model without the occupation variable. The results of the adjusted model are presented in the new version of the manuscript. 

**Comment:**Another question is how long the current differences between urban and rural contexts have existed? If some lifestyle changes are recent, there might be greater health differences across urban-rural contexts among the younger cohorts. In this case, there would be an interaction between age cohort and urban-rural difference. Similarly, is there a sex difference in exposures due to how modernization manifests? I noticed that the urban sample was much more female-biased, suggesting male out-migration or wage labor leading to greater male absenteeism.

**Response:**Thank you for this. In view of the cross-sectional nature of the study design, we were unable to determine how long the current differences in metabolic parameters between the rural and urban contexts have existed and to our knowledge, no study has previously assessed the urban-rural differences in metabolic outcomes in these populations. The rural population in particular is highly mobile, with only 9% having lived there all their lives (Table 1), therefore examining for an interaction between age cohort and urban-rural differences may not be informative.  We have expanded our discussion to highlight these consequences of the cross-sectional study design.

**Comment:**The authors mention the thrifty phenotype as a possible explanation for why people in the rural areas might be prone to glucose dysregulation. Thrifty phenotype and developmental origins of health and disease (DOHaD) paradigms emphasize the effects of early life exposures on later life chronic disease risk, especially when conditions shift over the life course (e.g. from harsh to abundant). That one-third of those living in the urban context were born and spent their first five years of life in a rural area permits one to explore the potential effects of developmental plasticity. A "purer" urban-rural contrast would be limited to those who spent their entire lives in the same environmental context. An additional exploration could test whether those who spent their early life in a rural context but now live in an urban context show worse cardiometabolic health than those who have spent their entire lives in a rural context. The authors have the data to make these comparisons, but do not include these early life variables in any analyses other than sample description (Table 1).

**Response:**Exploring the potential effects of plasticity on the metabolic outcomes and the "purer" rural-urban contrast limited to those who spent their entire lives in the same environmental context are excellent suggestions. However, these analyses were not preplanned and the surveys were not powered to measure them. With that in mind, we have performed this posthoc analysis and the results are shown in tables [1](https://s3-eu-west-1.amazonaws.com/wellcomeopenresearch/linked/234031.Table_1.png) and [2](https://s3-eu-west-1.amazonaws.com/wellcomeopenresearch/linked/234032.Table_2.png). We did not find differences in HOMA-IR and fasting glucose between individuals in the urban environment who spent their entire lives in the urban environment and those who were born and lived in the rural environment for the first five years and later moved to the urban environment ( [table 1](https://s3-eu-west-1.amazonaws.com/wellcomeopenresearch/linked/234031.Table_1.png)).

For the "purer" rural-urban analysis limited to individuals who spent their entire lives in the same environment ( [table 2](https://s3-eu-west-1.amazonaws.com/wellcomeopenresearch/linked/234032.Table_2.png)), we still found differences in fasting glucose and blood pressure, as in the main analysis. However, the difference in HOMA-IR, observed in the main analysis was lost here.

The number of individuals analysed was far smaller than in the main analysis, and this cannot be ruled out as a reason for the discrepancy in the two findings. However, we do appreciate the input and will factor this in when designing rural-urban comparison studies in the future.

**Comment:**Lastly, while the authors speculate that sleep disruption and altered circadian rhythms might explain the surprising finding that fasting glucose is higher in the rural context, a simpler (but less interesting) possibility is that people in a rural context may be less likely to adhere to the requirement of an overnight fast prior to blood draw (especially if as noted, night fishing is a common activity in the rural setting). In the future, glycosylated hemoglobin (HbA1c) could be measured to provide a more reliable, long-term indicator of glucose levels.

**Response:** Thank you for this suggestion - we have revised the manuscript to include this possibility.

**Comment:**Also, although maybe less relevant, it was unclear whether there are ethnic differences within or between sampling areas that might reflect genetic differences underlying health risk.

**Response:**There were no ethnic differences between the sampling areas. This is shown in table 1 where reference is made to parental tribe.

**Comment:**Overall, this is a nice epidemiological study highlighting imminent chronic disease risks in Uganda, showcasing that such risks are not restricted to urban areas. Prevalence rates of hypertension and central obesity are noteworthy in both urban and rural contexts.

Minor:

**Comment:**Given lower response rate due to absenteeism in the urban sample, are absent individuals more or less likely to show any health differences than those at home (e.g. more involved in wage labor, and perhaps more integrated into market economy)? If data exist for only one round of data collection then maybe this potential for bias cannot be checked.

**Response:**Unfortunately, there was only one urban survey. We did not explore the health differences between individuals who were present at home and those absent because the individual questionnaires used to capture these data were only administered to participants who were present.

**Comment:**Any current use of medications, e.g. for hypertension? If so, are those individuals excluded from analyses of biomarkers?

**Response:** Current use of medications especially for hypertension, was uncommon and therefore these individuals were not excluded from the analysis.

[^1]: No competing interests were disclosed.
